Found: 8
Select item for more details and to access through your institution.
Impact of the Glucagon Assay When Assessing the Effect of Chronic Liraglutide Therapy on Glucagon Secretion.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Two‐year trial of intermittent insulin therapy vs metformin for the preservation of β‐cell function after initial short‐term intensive insulin induction in early type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1399, doi. 10.1111/dom.13236
- By:
- Publication type:
- Article
Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 744, doi. 10.1111/dom.12858
- By:
- Publication type:
- Article
Liraglutide and the Preservation of Pancreatic [beta]-Cell Function in Early Type 2 Diabetes: The LIBRA Trial.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial.
- Published in:
- Diabetes Care, 2014, v. 37, n. 12, p. 3270, doi. 10.2337/dc14-0893
- By:
- Publication type:
- Article
Glycemic Variability in Patients With Early Type 2 Diabetes: The Impact of Improvement in [beta]-Cell Function.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Glycemic Variability in Patients With Early Type 2 Diabetes: The Impact of Improvement in β-Cell Function.
- Published in:
- Diabetes Care, 2014, v. 37, n. 4, p. 1116, doi. 10.2337/dc13-2591
- By:
- Publication type:
- Article